Rangering i aksjer
#15162
Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development... Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Aksjekurs
$3.70
Sist synkronisert: 2026-08-28
Handel Hansa Biopharma AB (HNSBF)
Pris HNSBF pris med markedsverdi på B
Markedsverdi av Hansa Biopharma AB(HNSBF)
Markedsverdi: $369.01M
Per September 2026 har Hansa Biopharma AB en markedsverdi på $369.01M. Dette gjør Hansa Biopharma AB til det 15162nd mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Hansa Biopharma AB fra 2015 til 2026
HNSBF sammenlignet med topp 5 mest populære stocks
| Pris på HNSBF |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.327T
|
+1,443,420.27%
|
|
|
|
|
$4.645T
|
+1,258,623.57%
|
|
|
|
|
$4.070T
|
+1,102,907.32%
|
|
|
|
|
$3.785T
|
+1,025,490.33%
|
|
|
|
|
$2.790T
|
+756,000.51%
|
